|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 160.50 ARS | 0.00% |
|
0.00% | -33.26% |
| Market Cap | 6.84B 4.77M 4.11M 3.78M 3.55M 6.67M 451M 6.74M 44.72M 17.42M 221M 17.9M 17.52M 765M | P/E Ratio 2024 |
-3.67x | P/E Ratio 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 7.57B 5.28M 4.55M 4.19M 3.94M 7.39M 499M 7.47M 49.54M 19.3M 245M 19.83M 19.41M 848M | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| Current month | -3.60% | ||
| 3 months | -13.94% | ||
| 6 months | -25.69% | ||
| Current year | -33.26% |
| 1 week | 160 | 169.5 | |
| 1 month | 155 | 176.5 | |
| Current year | 128.5 | 260 | |
| 1 year | 116 | 357 | |
| 3 years | 21 | 450 | |
| 5 years | 9.1 | 450 | |
| 10 years | 4 | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 2010-07-29 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2010-07-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -57.76% | +669.78% | 4.77M | ||
| -0.78% | -3.49% | -51.74% | -53.54% | 33.26B | ||
| -0.25% | -1.10% | +73.20% | +133.65% | 12.1B | ||
| -3.36% | -4.21% | +1.56% | +23.33% | 4.46B | ||
| -0.15% | -1.75% | +6.15% | +17.86% | 3.28B | ||
| -0.80% | +3.43% | +63.11% | +28.69% | 2B | ||
| -2.61% | +6.40% | -23.92% | +2.77% | 1.78B | ||
| -1.27% | -2.39% | +28.98% | +130.61% | 1.29B | ||
| -1.39% | +2.02% | -22.24% | -10.21% | 1.05B | ||
| -1.77% | +1.22% | -5.00% | -45.45% | 1B | ||
| Average | -1.24% | +0.31% | +1.23% | +89.75% | 6.02B | |
| Weighted average by Cap. | -0.92% | -2.09% | -11.88% | +2.95% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.27B 5.77M 4.97M 4.58M 4.3M 8.08M 546M 8.16M 54.13M 21.09M 267M 21.66M 21.2M 926M | 6.4B 4.47M 3.85M 3.55M 3.33M 6.25M 422M 6.32M 41.89M 16.32M 207M 16.76M 16.41M 717M |
| Net income | -1.42B -989K -852K -785K -737K -1.38M -93.48M -1.4M -9.27M -3.61M -45.78M -3.71M -3.63M -159M | -4.6B -3.21M -2.76M -2.55M -2.39M -4.49M -303M -4.53M -30.08M -11.72M -148M -12.04M -11.78M -515M |
| Net Debt | 863M 602K 519K 478K 449K 842K 56.93M 851K 5.65M 2.2M 27.88M 2.26M 2.21M 96.61M | 738M 515K 444K 408K 383K 720K 48.66M 728K 4.83M 1.88M 23.83M 1.93M 1.89M 82.57M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-16 | 160.50 $ | 0.00% | 16,450 |
| 26-06-12 | 160.50 $ | -0.62% | 4,200 |
| 26-06-11 | 161.50 $ | 0.00% | 9,352 |
| 26-06-10 | 161.50 $ | +0.62% | 11,082 |
| 26-06-09 | 160.50 $ | +0.31% | 12,579 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
















